Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business
  2. Equipment
  3. usa washington
  4. preclinical data from cytotil15 program
Show results for
Refine by
Locations
Back to All Locations
Brands

Lung Therapeutics Preclinical Data From Cytotil15 Program Equipment & Supplies In In Usa Washington

1 equipment items found
Lung Therapeutics - Model LTI-03 - Revolutionary Compound for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)

Lung Therapeutics - Model LTI-03 - Revolutionary Compound for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)

Manufactured by:Lung Therapeutics, Inc.   based inAustin, TEXAS (USA)
Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease characterized by progressive tissue scarring that prevents proper lung function. LTI-03 operates through a novel mechanism of action (MOA) that is unlike any MOA seen in the therapeutic candidates of today. By targeting healthy epithelial cells, LTI-03 promotes the protection of lung epithelium while inhibiting fibroblast growth and ...
CONTACT SUPPLIER
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you